PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Douglas Wettergren appointed as CEO of DoKaSch Americas, Inc.

 DoKaSch Temperature Solutions is expanding its USA operations with a new structure:  DoKaSch Americas Inc., based in San Francisco, California, will be the first line of contact with clients in the USA and Canada. Senior industry expert Douglas Wettergren has joined the company as CEO, effective immediately. “Douglas knows the needs of the pharmaceutical industry, especially regarding cool-chain transports from the inside out”, said Andreas Seitz, Managing Director of DoKaSch Temperature Solutions. “Douglas will focus on our clients across the United States and Canada.”
Wettergren’s main duties will be sales and business development for DoKaSch’s “flying-aircon warehouse” Opticooler® RAP and RKN to pharmaceutical and forwarding companies. Opticoolers are climate-controlled air cargo containers with unmatched reliability. Since last year, Opticoolers are also based at designated locations in the US in order to provide them quickly to clients across North America. In two large areas, delivery to clients is almost free of charge. “I am excited to join DoKaSch”, says Wettergren. “I see many opportunities for Opticoolers in the U.S. and beyond. Our technical features, extraordinary reliability, and availability policy provide us a unique opportunity to offer something special. Due to our comprehensive network in the USA and Canada, we can serve clients quickly and dependably. It is truly a fantastic opportunity to be involved in expanding such a high level of quality to the global market.” Wettergren is a well-connected industry veteran. He is currently serving on the Bio Supply Management Alliance (BSMA) Steering Committee and is an Advisory Board Member for IQPC in Chicago/Boston.  He has been a member of the PDA since 2007.
The containers provide reliable transport conditions for shipments across continents and climate zones or during unexpected events, for goods that must be kept within a very strict temperature range. Equipped with battery powered cooling compressors and heaters as well as a self-regulating temperature control, the internal temperatures consistently stay well within range at any point in the storage area. Temperatures between 2 to 8°C or 15 to 25°C for example can be maintained, regardless of the ambient temperatures, that may vary between minus 30°C during a Canadian winter or plus 50°C during a summer in the Middle East.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026